In the letter dated Aug. 8, ASL Strategic Value says several missteps in recent years have led to the downfall of CHS, including the company’s 2014 acquisition of Health Management Associates in Naples, Fla.
“It is time for the board to exercise its fiduciary duty to the shareholders and replace the current CEO,” states the letter from ASL.
After the letter was released, CHS shares climbed more than 11 percent in afternoon trading to $7.80 per share, according to Reuters.
More articles on healthcare finance:
CMS cancels cardiac bundles, scales back CJR model: 8 things to know
IRS revokes hospital’s tax-exempt status for failure to comply with ACA rule
Tenet board upheaval could lead to activist campaign
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
